The Influence of Different Exercise Patterns on the Incidence of Coronary Heart Disease in the Western Collaborative Group Study1

2015 ◽  
pp. 267-273
Author(s):  
R. H. Rosenman
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Collaborative Group

Coronary heart disease in the Western Collaborative Group Study

1970 ◽  
Vol 23 (3) ◽  
pp. 173-190 ◽  
Author(s):  
Ray H. Rosenman ◽  
Meyer Friedman ◽  
Reuben Straus ◽  
C.David Jenkins ◽  
Stephen J. Zyzanski ◽  
...  
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Collaborative Group

Competitive drive, pattern a, and coronary heart disease: A further analysis of some data from the Western Collaborative Group Study

1977 ◽  
Vol 30 (8) ◽  
pp. 489-498 ◽  
Author(s):  
Karen A. Matthews ◽  
David C. Glass ◽  
Ray H. Rosenman ◽  
Rayman W. Bortner
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Collaborative Group

Prevalence of Metabolic Syndrome and Coronary Heart Disease Risk in Patients with Schizoaffective Disorder: Clamors Study

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
C. Arango ◽  
J. Bobes ◽  
P. Aranda ◽  
R. Carmena ◽  
M. Garcia-Garcia ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
High Risk ◽  
Schizoaffective Disorder ◽  
Disease Risk ◽  
Collaborative Group ◽  
Antipsychotic Treatment ◽  
Chd Risk ◽  
Very High

Aims:To assess the prevalence of metabolic syndrome (MS) and the coronary heart disease (CHD) risk in patients with schizoaffective disorder treated with antipsychotics.Methods:Schizoaffective patients from a multicentre cross-sectional study, in which 117 psychiatrists recruited consecutive outpatients meeting DSM-IV criteria for schizophrenia, schizophreniform or schizoaffective disorder and receiving antipsychotic treatment in monotherapy for at least 12 weeks. MS was defined as fulfilment of at least 3 of the following components (NCEP-ATP-III definition): waist circumference >102(men)/>88(women) cm; triglycerides >=150mg/dL; HDL-cholesterol < 40mg/dL(men)/< 50mg/dL(women); blood pressure >=130/85; fasting glucose >=110mg/dL. CHD risk was assessed by SCORE (10-year CV death) and Framingham (10-year all CV events) functions.Results:268 valuable patients with schizoaffective disorder (127 men, 48.1%), 41.9±12.3 years (mean±SD) were examined. MS was presented in 26.5% (95%CI:21.2-31.8) of subjects [26.8% in men (19.1-34.5), 27.0% (19.6-34.4) in women (p=0.966)]. the overall 10-year CV risks (CV death or any event) were 0.8±1.6 (SCORE) and 6.5±6.8 (Framingham), respectively. the 8.4% (95%CI:5.0-11.8) and 20.1% (95%CI:15.2-24.9) of patients showed high/very-high risk according to SCORE (≥3%) and Framingham (≥10%), respectively. A high/very-high risk of any CV event (Framingham≥10%) was associated with age above 40(men)/45(women) years [OR: 32.44 (9.59-109.71, p< 0.001)], and CGI-S=3-4; [OR: 4.32 (1.15-16.26, p=0.03)]. Women showed lower risk of any CV event [OR: 0.30 (0.14-0.65, p=0.002)].Conclusions:MS prevalence and CHD risk were high among patients with schizoaffective disorder treated with antipsychotics. Gender, age and poor disease control could be associated with CHD risk.*On behalf of the CLAMORS Collaborative Group.

Sign in / Sign up

Export Citation Format

Share Document